Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,741,290 papers from all fields of science
Search
Sign In
Create Free Account
Etoposide/Ifosfamide regimen
Known as:
EIM
, IFF/VP-16
, ifosfamide etoposide
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Etoposide
Ifosfamide
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Ethanol injection into the Marshall vein provoking a pericardial effusion resulting in a fatal complication in a patient with persistent atrial fibrillation
Kazuo Kato
,
O. Igawa
,
Shin Morimoto
,
R. Kametani
,
A. Tanaka
,
Hideo Hattori
Clinical Case Reports
2017
Corpus ID: 27023633
An EIM (ethanol infusion into the vein of Marshall [VOM]) provoked a fatal complication in a chronic hemodialysis patient…
Expand
2015
2015
Benefit of Earlier Anti-TNF Treatment on IBD Disease Complications?
V. Nuij
,
G. Fuhler
,
+11 authors
C. J. van der Woude
Journal of Crohn's & Colitis
2015
Corpus ID: 18246608
BACKGROUND Anti-tumour necrosis factor [anti-TNF] treatment was demonstrated to have disease-modifying abilities in inflammatory…
Expand
Review
2015
Review
2015
Pancreatic involvement in pediatric inflammatory bowel diseases
S. Cardile
,
A. Randazzo
,
S. Valenti
,
C. Romano
World Journal of Pediatrics
2015
Corpus ID: 46088618
BackgroundInflammatory bowel diseases (IBDs) are a group of chronic diseases affecting the gastrointestinal tract, with a…
Expand
2013
2013
Probable Cytarabine-induced Acral Erythema: Report of 2 Pediatric Cases
S. Ozmen
,
M. Doğru
,
C. Bozkurt
,
Ayse Ceyda Kocaoglu
Journal of pediatric hematology/oncology
2013
Corpus ID: 32234111
Acral erythema (palmoplantar erythrodysesthesia) is a localized skin side effect that is seen most often in patients receiving…
Expand
2008
2008
Treatment of relapsed acute myeloid leukemia with MLL/AF6 fusion after allogeneic hematopoietic stem cell transplantation with gemtuzumab ozogamicin with a long interval followed by donor lymphocyte…
H. Tamai
,
Y. Shioi
,
+7 authors
K. Dan
Leukemia
2008
Corpus ID: 5768293
Treatment of relapsed acute myeloid leukemia with MLL/AF6 fusion after allogeneic hematopoietic stem cell transplantation with…
Expand
2006
2006
Topotecan, thiotepa, and carboplatin for neuroblastoma: failure to prevent relapse in the central nervous system
B. Kushner
,
K. Kramer
,
+4 authors
N. K. Cheung
Bone Marrow Transplantation
2006
Corpus ID: 23927102
We report on a three-drug myeloablative regimen designed to consolidate remission and to prevent central nervous system (CNS…
Expand
Review
2004
Review
2004
Extended intestinal metaplasia. A survey of 1392 gastrectomies from dwellers of the Pacific basin.
C. Rubio
,
T. Hirota
,
+5 authors
Y. Kato
Anticancer Research
2004
Corpus ID: 5673212
BACKGROUND To assess the extent of gastric intestinal metaplasia (IM) in gastrectomy specimens in populations of the Pacific…
Expand
Review
1995
Review
1995
Etoposide-platin combination therapy for chemorefractory gestational trophoblastic disease.
J. Soper
,
A. C. Evans
,
G. Rodriguez
,
A. Berchuck
,
D. Clarke‐Pearson
,
C. Hammond
Gynecologic Oncology
1995
Corpus ID: 23468554
The purpose of this study was to determine activity of etoposide-platin combination chemotherapy for chemorefractory gestational…
Expand
1994
1994
Uterine myxoid leiomyosarcoma and CYVADIC‐etoposide therapy
H. Fukunishi
,
N. Yukimura
,
S. Takeuchi
,
S. Kitazawa
International journal of gynaecology and…
1994
Corpus ID: 40814063
1989
1989
ProMACE-CytaBOM: combination chemotherapy for diffuse large cell lymphoma.
M. Prokocimer
,
M. Modan
,
S. Rusoshansky
,
O. Bairey
,
M. Shaklai
Anticancer Research
1989
Corpus ID: 3085114
ProMACE CytaBOM, a polychemotherapy regimen consisting of cyclophosphamide, doxorubicin, etoposide cytozar, bleomycin…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE